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A biophysical model of radiation-induced cell death and chromosome aberrations [called 
BIophysical ANalysis of Cell death and chromosome Aberrations (BIANCA)] was further 
developed and applied to therapeutic protons. The model assumes a pivotal role of DNA 
cluster damage, which can lead to clonogenic cell death following three main steps: 
(i) a DNA “cluster lesion” (CL) produces two independent chromosome fragments; (ii) 
fragment mis-rejoining within a threshold distance d gives rise to chromosome aberra-
tions; (iii) certain aberration types (dicentrics, rings, and large deletions) lead to clonogenic 
inactivation. The yield of CLs and the probability, f, that a chromosome fragment remains 
un-rejoined even if other fragment(s) are present within d, were adjustable parameters. 
The model, implemented as a MC code providing simulated dose–responses directly 
comparable with experimental data, was applied to pristine and modulated Bragg 
peaks of the proton beam used to treat eye melanoma at INFN-LNS in Catania, Italy. 
Experimental survival curves for AG01522 cells exposed to the Catania beam were 
reproduced, supporting the model assumptions. Furthermore, cell death and chromo-
some aberrations at different depths along a spread-out Bragg peak (SOBP) dose profile 
were predicted. Both endpoints showed an increase along the plateau, and high levels 
of damage were found also beyond the distal dose fall-off, due to low-energy protons. 
Cell death and chromosome aberrations were also predicted for V79 cells, in the same 
irradiation scenario as that used for AG01522 cells. In line with other studies, this work 
indicated that assuming a constant relative biological effectiveness (RBE) along a proton 
SOBP may be sub-optimal. Furthermore, it provided qualitative and quantitative evalua-
tions of the dependence of the beam effectiveness on the considered endpoint and dose. 
More generally, this work represents an example of therapeutic beam characterization 
avoiding the use of experimental RBE values, which can be source of uncertainties.
Keywords: cell death, chromosome aberrations, protons, hadron therapy, biophysical models, Monte carlo 
simulations, relative biological effectiveness
inTrODUcTiOn
According to the Particle Therapy Co-operative Group1, 49 proton therapy centers were operating 
and 32 were under construction in June 2015. The rationale of using protons instead of conventional 
radiotherapy relies on the ability of these particles to reduce the dose to normal tissues, thanks to the 
dose localization in the (spread-out) Bragg peak (SOBP) (1). In addition to different types of tumors, 
1 http://www.ptcog.ch/
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protons can also be used to treat non-cancer diseases, such as 
arteriovenous malformations (2).
Protons are usually considered low-LET radiation, and a con-
stant relative biological effectiveness (RBE) of 1.1, mainly derived 
from animal experiments, is generally applied in the clinical 
practice. However, both in vitro and in vivo studies indicate that 
proton effectiveness increases with decreasing energy, which is 
increasing LET. This implies an increase of effectiveness with 
depth along the SOBP, as well as an extension of the biologically 
effective range. In vivo, the average RBE at mid-SOBP is ~1.1, 
ranging from 0.7 to 1.6 (3); in vitro data on clonogenic cell sur-
vival indicate an average value at mid-SOBP of ~1.2, ranging from 
0.9 to 2.1 (3). Furthermore, the RBE depends not only on the 
particle energy but also on many other factors, including dose, 
dose-rate, cell type, and biological endpoint. For instance, both 
in vitro and in vivo data show a significant RBE increase for lower 
fractional doses [e.g., Ref. (4, 5)], especially for cells and tissues 
with low α/β ratio (6). This may be one of the reasons why in vivo 
experiments, most of which have been performed at higher doses, 
suggest lower RBE values with respect to in vitro studies. It should 
also be considered that, although the main endpoint of interest 
for tumor cells is cell death, other endpoints (e.g., mutations, 
non-lethal chromosome aberrations, etc.) might be relevant for 
normal tissues.
Although clinical results do not indicate that the use of a 
constant RBE is incorrect, no trials specifically targeted RBE 
variations; moreover, tighter treatment margins may increase the 
importance of taking into account such variations (7). Applying a 
constant RBE of 1.1 may lead to an underestimation of the dam-
age to normal tissues, especially for treatments involving organs 
at risk just beyond the tumor, such as the retina for eye tumors 
and the heart for (left) breast tumors, which are becoming a major 
application of protontherapy [e.g., Ref. (8)]. On the other side, 
the currently available RBE data might be insufficient to support 
a change in clinical practice (7). Incorporating variations in bio-
logical effectiveness without directly considering the RBE may 
be an alternative strategy. For instance, it has been suggested that 
LET distributions in the patient can be used to guide treatment 
plan optimization (9).
In this framework, a biophysical model of radiation-induced 
cell death and chromosome aberrations called BIophysical 
ANalysis of Cell death and chromosome Aberrations (BIANCA) 
(10–13) was developed at the University of Pavia and INFN-
Pavia, Italy. The model, which in the last few years has been 
tested against in vitro cell survival data and has been applied in 
the framework of Boron Neutron Capture Therapy (14), assumes 
that DNA cluster damage can lead to chromosome aberrations 
and that some aberration types lead to clonogenic cell death. 
This approach allows calculating cell survival without relying 
on the concept of RBE. Furthermore, the capability of the model 
to calculate the induction of different chromosome aberration 
types, in addition to cell death, makes it suitable for applications 
in the framework of normal tissue damage evaluation, since 
some chromosome aberrations are known to be related to the 
risk to normal tissues (15). In the present work, after comparing 
simulated dose–response curves for chromosome aberrations 
with experimental data taken from the literature, the model was 
applied to the 62-MeV proton beam used to treat ocular mela-
noma at the CATANA facility of INFN-LNS in Catania, Italy (16). 
Experimental survival curves taken from the literature (17) for 
AG01522 cells exposed to pristine and SOBPs from the CATANA 
beam were reproduced, and cell death and chromosome aberra-
tions were calculated for different depth positions along a SOBP. 
Finally, cell death and chromosome aberrations were predicted 
for another cell line (V79) exposed to the same dose profile used 
for AG01522 cells.
MaTerials anD MeThODs
Model assumptions
The BIANCA model is based on the following assumptions: (1) 
radiation induces DNA “cluster lesions” (CLs), and each CL 
gives rise to two independent chromosome fragments; (2) two 
chromosome fragments can undergo rejoining only if their 
initial distance is smaller than a threshold distance d, leading to 
chromosome aberrations in case of mis-rejoining (accidental un-
rejoining is allowed); and (3) dicentrics, rings, and large deletions 
lead to clonogenic cell death.
A characterization of the “critical” DNA damage(s), which 
is damage type(s) that can lead to important endpoints such as 
chromosome aberrations and cell death, is still an open question 
in radiobiology. Therefore, we chose not to provide a definition 
for the quantity “CL,” leaving the mean number of CLs per unit 
radiation dose and per unit DNA mass (that is, the mean number 
of CLs per Gy and per Dalton, which can be easily converted into 
CLs per Gy and per cell) as an adjustable parameter. In a previous 
work (13), CL yields for different radiation qualities showed good 
agreement with yields of kilo-base-pair (kbp) DNA fragments, 
suggesting that DSB clusters at the kbp scale, possibly in addition 
to other levels of clustering, may play a relevant role.
Assumption (2) reflects the fact that fragment rejoining is 
thought to be distance dependent. The adoption of a step function, 
rather than a continuously decreasing function, implicitly takes 
into account the existence in the cell nucleus of repair centers, 
where DSBs should migrate for repair. For instance, 1–2 μm DSB 
migration distances have been estimated for MCF10A epithelial 
cells (18). In previous works [e.g., Ref. (13)], where the threshold 
distance d was considered as an adjustable parameter, a d value of 
5 μm led to good agreement with experimental survival curves for 
AG1522 human fibroblasts and V79 hamster fibroblasts exposed 
to different radiation qualities. However, this value seems to be 
larger than most estimations available in the literature. In the pre-
sent work, a different approach was adopted, setting the value of 
d equal to the mean distance between two adjacent chromosome 
territories (which resulted to be 3.0 μm for AG cells and 3.6 μm 
for V79 cells), basing on the idea that repair mainly takes place 
in small channels separating adjacent chromosome domains 
(19). The expression “chromosome territories” refers to distinct 
regions of the cell nucleus, with negligible reciprocal overlapping, 
where the various chromosomes are localized during interphase, 
that is most of the cell cycle. According to this approach, d is no 
more an adjustable parameter, but is fixed a priori basing on the 
specific features of the considered cell nucleus (i.e., nucleus shape 
and dimensions and number of chromosomes).
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In previous works, a chromosome fragment having at least 
one potential partner for rejoining (that is, at least another frag-
ment within the threshold distance d) was assumed to undergo 
rejoining with 100% probability. On the contrary in the present 
work, we considered a more realistic scenario where a fragment, 
even if one or more potential “partners” are available within d, 
has a given probability f of remaining un-rejoined. This assump-
tion is consistent with studies indicating that a certain fraction 
of exchange-type chromosome aberrations are “incomplete,” i.e., 
not all the involved chromosome fragments are finally rejoined 
[e.g., Ref. (20–22)]. The observed probability of unrejoining tends 
to be cell-line-dependent, since in general radiosensitive cells 
show higher frequencies of deletions with respect to normal or 
radioresistant cells. For instance, in ataxia-telangiectasia (A-T) 
cells exposed to X-rays, the fraction of un-rejoined breaks was 
five to six times higher than that for normal fibroblasts (23). 
Concerning a possible dependence on radiation quality, contra-
dicting results can be found in the literature. While some works 
report an increase of incomplete exchanges with LET [e.g., Ref. 
(21)], others do not indicate a LET-dependence [e.g., Ref. (20, 
22)]. For the sake of simplicity, in the present work we assumed 
that, for a given cell line, the value of f was cell line dependent but 
LET independent.
Assumption (3) derives from the relationship between 
chromosome aberrations and cell death shown by many works 
available in the literature. In particular, for AG1522 fibroblasts 
exposed to X-rays, Cornforth and Bedford (24) found a one-to-
one relationship between the mean number per cell of “Lethal 
Aberrations” (defined as dicentrics plus rings plus deletions 
visible in Giemsa) and –lnS, where S is the fraction of surviving 
cells. According to another work, an analogous relationship may 
hold for V79 cells as well (25).
Dose–response simulations
Like in previous works, AG1522 cell nuclei were modeled as 
cylinders with elliptical base (height: 4 μm; major axis: 20 μm; 
minor axis: 10 μm), and V79 cell nuclei were modeled as cyl-
inders with circular base (height and radius: 6 μm). A discus-
sion on these choices can be found in Carante et al. (13). Each 
interphase chromosome territory was represented as the union 
of adjacent cubic voxels of 0.2 μm side to obtain chromosome 
territories with volume proportional to their DNA content. The 
various territories were simultaneously constructed step-by-step, 
with the first step consisting of random selection of a “starting 
voxel” for each chromosome territory. In each of the subsequent 
steps, a new voxel was assigned to each territory; the new voxel 
was randomly selected among the six closest neighbors of the 
voxel that was assigned to that territory in the preceding step. 
After constructing the various chromosome territories, each of 
the voxels assigned to a given territory was associated with one of 
the two chromosome arms, applying a probability proportional 
to the arm DNA content.
To simulate the exposure to a given dose of X-rays, a CL yield 
(mean number of CLs per Gy and per cell) was multiplied by that 
dose to obtain the mean number of CLs per cell. For each cell, 
which is for each run of the code, an “actual” number of CLs was 
then extracted from a Poisson distribution, and those CLs were 
distributed within the nucleus volume uniformly, since X-rays 
are sparsely ionizing radiation. For protons, the simulation for 
a given dose started calculating the mean number of (primary) 
particles traversing the cell nucleus, with direction parallel to the 
axis of the cylinder representing the nucleus. Such mean number 
was calculated by n = S × D/(0.16 × L), where S is the nucleus 
cross-sectional area in square micrometer, D is the absorbed dose 
in Gy, L is the radiation LET in keV/μm, and 0.16 is a factor com-
ing from the conversion between eVs and Joules. For each cell, an 
“actual” number of nucleus traversals was then extracted from a 
Poisson distribution having mean value n, and for each traversal 
an entrance point in the nucleus was randomly selected. The 
mean number of CLs per nucleus traversal was then calculated 
multiplying the nucleus traversal length (in micrometer) by the 
mean number of CLs per micrometer. The latter was obtained 
by CL/μm = 0.16 ×  (CL⋅Gy−1⋅cell−1) × L/V, where V is the cell 
nucleus volume in cubic micrometer, L is the radiation LET in 
keV/μm, and 0.16 is the conversion factor mentioned above. For 
each nucleus traversal, an “actual” number of CLs was extracted 
from a Poisson distribution, and these CLs were uniformly dis-
tributed along the segment representing that traversal.
The subsequent simulation steps consisted of the following: 
identification of the chromosome and the chromosome-arm that 
was hit by each CL; rejoining of chromosome fragments within 
the threshold distance d; scoring of lethal aberrations (dicentrics, 
rings and deletions visible in Giemsa); and calculation of the 
corresponding surviving fraction. Chromosome fragments hav-
ing a DNA content smaller than 3 Mega-base-pairs (Mbp) were 
assumed as not visible in metaphase, as reported by Cornforth and 
Bedford (24). A discussion on the role of this value can be found 
in Carante et  al. (13). For each dose, the code was run 10,000 
times, allowing to obtain a relative error smaller than 2%. The 
repetition for different doses provided simulated dose–response 
curves for chromosome aberrations or cell survival, directly 
comparable with experimental data.
resUlTs anD DiscUssiOn
chromosome aberrations
According to the approach adopted in the current version of the 
model, (clonogenic) cell death depends on chromosome aberra-
tions, in particular the so-called “lethal aberrations” (dicentrics, 
rings, and deletions). Comparisons between calculated and 
experimental yields of different chromosome aberration types 
have been published in previous works [e.g., Ref. (12, 26–29)]. 
However, new comparisons were performed following the 
introduction of some modifications: in the present work, as 
mentioned above, the threshold distance for chromosome frag-
ment rejoining, d, was fixed as the mean distance between two 
adjacent chromosome territories, and a chromosome fragment 
was allowed to remain un-rejoined (with probability f) also when 
possible “partners” were present within d.
A detailed and systematic discussion on this issue is beyond 
the scope of the present work, and will be object of a separate 
paper. As an example, Figure 1 shows dose–response curves for 
dicentrics, rings, and deletions (both separately and summed 
up to give total aberrations) induced in AG1522 cells exposed 
FigUre 1 | Yields (mean number per cell) of different aberration types 
(dicentrics, rings, and deletions, as well as total lethal aberrations) in 
ag1522 primary normal human fibroblasts exposed to different doses 
of X-rays. The lines are simulation outcomes, the points are experimental 
data taken from Cornforth and Bedford (24).
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to X-rays. The lines are simulation outcomes, the points are 
experimental data taken from the literature (24). The error bars 
associated with the experimental points, which represent 95% 
confidence about means as reported in Ref. (24), were calculated 
from the aberration yields and the number of analyzed cells 
reported in table 2 of the experimental paper. Both for dicen-
trics and rings, the calculated aberration yields were within the 
experimental errors, with the only exception of dicentrics at 6 Gy. 
Incidentally, the capability of reproducing separately the yields of 
dicentrics and rings supports the assumption adopted for d, since 
higher d values overestimated the ratio of dicentrics to rings (the 
so-called “F-ratio”), whereas lower d values underestimated the 
F-ratio (results not shown). Concerning deletions, the question 
seems more qualitative than quantitative: while the simulated 
response is basically linear, the experimental response shows 
a non-negligible quadratic component. This can be explained 
considering that in the simulations most deletions were “terminal 
deletions,” which being due to a single chromosome break involve 
a single-particle mechanism proportional to dose, whereas most 
experimental deletions were of the “interstitial” type, which 
requiring two chromosome breaks (also) involves a two-particle 
mechanism proportional to the square of dose. The observation 
of so many interstitial deletions following exposure to X-rays, 
which are sparsely ionizing radiation, is not easy to explain. One 
possible reason might be related to the particular experimental 
protocol, according to which the cells were sub-cultured for 24 h 
after irradiation.
The curves reported in Figure 1 were obtained with a f value 
of ~0.2, and a CL yield of ~1.3 CL Gy−1⋅cell−1. This value is lower 
than the value used to reproduce total aberration yields in previ-
ous works [e.g., Ref. (12)] where parameter f was not introduced, 
which means f = 0. This can be explained considering that in 
the present work, where a chromosome fragment is allowed to 
remain un-rejoined also in presence of potential partners within 
the threshold distance, the yield of deletions – and thus of total 
aberrations  –  increased, implying that a lower CL yield was 
sufficient to get the same yield of total aberrations. Although 
it was possible to reproduce the yields of total aberrations also 
assuming that f = 0 (12), at most doses the yields of deletions 
were underestimated by a factor ~2, and the yields of dicentrics 
were overestimated, again by a factor ~2. On the contrary, as 
shown in Figure 1, the introduction of a f value higher than 0 
allowed obtaining a good agreement not only with total aber-
rations as a whole (upper curve) but also with dicentrics, rings, 
and deletions considered separately (three lower curves). A 
determination of the “best” f value was beyond the scope of the 
present work. However, it is worth reporting that attempting 
to reproduce the (experimental) yields of total aberrations with 
lower f values (and higher CL yields) led to an underestimation 
of deletions associated with an overestimation of dicentrics, 
whereas higher f values (with lower CL yields) led to an over-
estimation of deletions associated with an underestimation of 
dicentrics (results not shown).
survival curves
The model was then applied to cell survival, focusing on protons 
due to their wide use in hadron therapy. The first step of the work 
consisted of reproducing experimental survival curves obtained 
with the 62-MeV proton beam available at the CATANA ocular 
melanoma facility of INFN-LNS in Catania, Italy (16, 17). In that 
experiment (17), AG01522 primary normal human fibroblasts 
were exposed to six pristine Bragg peaks (with minimum and 
maximum water-equivalent depth of 1.7 and 30.7 mm, respec-
tively) and at six depth positions along a SOBP (with minimum 
and maximum water-equivalent depth of 1.5 and 31.2 mm, respec-
tively). After irradiation, the cells were immediately trypsinized, 
counted, seeded, and incubated to allow for macroscopic colony 
formation; colonies consisting of at least 50 cells were scored as 
viable. Further details can be found in the original paper (17).
Figure 2 reports simulated survival curves for the six pristine 
peaks (corresponding to the following LET values: 1.1, 4.0, 7.0, 
11.9, 18.0, and 22.6  keV/μm), together with the experimental 
data for comparison and their error bars, which represent 
one SD. Raw numbers were obtained from the authors of the 
experimental work. All simulations were performed adopting 
the same value of f used to calculate chromosome aberrations in 
AG human fibroblasts, which is 0.2. On the contrary, the yield of 
CLs, which depends on radiation quality, was adjusted separately 
for each curve. The curves reported in Figure 2 were obtained 
using CL yields in the range ~4.1–8.0 CL Gy−1⋅cell−1, increasing 
with the radiation LET. The increase with LET is consistent with 
the clustering nature of CLs [e.g., Ref. (28, 30)]. Analogous to 
chromosome aberrations, the CL yields used to obtain the curves 
shown in Figure 2 were (slightly) lower with respect to those used 
in previous works. Again, this is related to the introduction of 
parameter f, which implying higher yields of lethal aberrations, 
also implies lower survival levels; as a consequence, a lower CL 
yield was sufficient to get the same survival curve for a given 
radiation quality. In general, the simulation outcomes showed 
satisfactory agreement with the experimental data. In some 
FigUre 3 | cell survival curves for ag01522 primary normal human 
fibroblasts irradiated at six depth positions along a proton sOBP 
(corresponding to the following dose-averaged leT values: 1.2, 2.6, 
4.5, 13.4, 21.7, and 25.9 keV/μm). The lines are simulation outcomes, the 
points are experimental data taken from Chaudhary et al. (17).
FigUre 2 | cell survival curves for ag01522 primary normal human 
fibroblasts exposed to six pristine proton Bragg peaks 
(corresponding to the following leT values: 1.1, 4.0, 7.0, 11.9, 18.0, 
and 22.6 keV/μm). The lines are simulation outcomes, the points are 
experimental data taken from Chaudhary et al. (17).
FigUre 4 | calculated fraction of inactivated cells (blue symbols) and 
calculated mean number of dicentrics per cell (green symbols) at 
different depths of the sOBP dose profile reported in chaudhary et al. 
(17), which is also shown in the figure (red symbols). Each quantity was 
normalized with respect to the proximal position. The lines are simply guides 
for the eye.
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cases, typically for curves corresponding to higher LET values, 
there was a tendency to underestimate the experimental survival 
at the highest considered dose, which was 3  Gy. This issue is 
under investigation. More specifically, for 1.1 and 4.0  keV/μm 
the value of the reduced chi-square was around 1. Higher values 
were found for the other four curves, mainly due to the point at 
3 Gy; however, at least in two cases (7.0 and 22.6 keV/μm), the 
simulations were close to the fit performed by the authors, since 
the relative difference between calculated and fitted survival was 
smaller than 20%.
In Figure 3, simulated survival curves are compared with the 
experimental data obtained by Chaudhary et al. at the six depth 
positions along the SOBP, corresponding to the following dose-
averaged LET values: 1.2, 2.6, 4.5, 13.4, 21.7, and 25.9 keV/μm. 
Again, all simulations were performed without changing the 
value of f, whereas the CL yield was adjusted separately for each 
radiation quality, that is for each curve. Despite a tendency to 
underestimate the experimental survival at high doses, already 
mentioned for the pristine peaks, CL yields in the range 
~3.7–6.4 CL Gy−1⋅cell−1, increasing with LET, led to a satisfactory 
agreement with the experimental curves. Analogous to the results 
for the pristine peaks, also for the spread-out peak the agreement 
between simulations and experiments was particularly good for 
the lower LET curves, since a reduced chi-square around 1 was 
obtained for 1.2, 2.6, and 4.5  keV/μm. Higher (reduced) chi-
square values were found for 13.4, 21.7, and 25.9 keV/μm, mainly 
due to the points at the highest doses (3 and 4 Gy). However, with 
the only exception of the point at 3 Gy for the 21.7 keV/μm curve, 
the relative difference between calculated and fitted survival was 
not larger than 20%. It is also worth mentioning that, since the 
higher LET values refer to the descending part of the SOBP, where 
the doses are lower, the underestimation of the experimental 
survival at high doses of higher LET did not lead to important 
consequences on the predictions of cell killing and chromosome 
aberrations along the SOBP dose profile that will be shown in 
Figures 4–9.
Interestingly, the CL yields used for the curves reported in 
Figure 3 were lower than the CL yields used for the pristine peaks 
(Figure 2). This is consistent with the higher RBE observed in 
the experimental work for the pristine peaks with respect to the 
SOBP (17), and may be related to the fact that a SOBP consists of 
a mixed radiation field that can only be associated with an average 
FigUre 8 | ri (ratio between proton-induced and X-ray-induced cell 
inactivation after the same dose, blue symbols), rla (ratio between 
proton-induced and X-ray-induced lethal aberrations after the same 
dose, red symbols), and rDic (ratio between proton-induced and 
X-ray-induced dicentrics after the same dose, green symbols) 
calculated at different depths of the sOBP dose profile used in 
chaudhary et al. (17), assuming a plateau dose of 2 gy. The lines are 
simply guides for the eye.
FigUre 7 | Predicted mean number of dicentrics per cell at different 
depths along the sOBP, assuming a plateau dose of 1 gy (green 
symbols), 2 gy (blue symbols), or 4 gy (red symbols). Each quantity was 
normalized with respect to the proximal position; the lines are simply guides 
for the eye.
FigUre 6 | Predicted fraction of inactivated cells at different depths 
along the sOBP, assuming a plateau dose of 1 gy (green symbols), 
2 gy (blue symbols), or 4 gy (red symbols). Each quantity was 
normalized with respect to the proximal position. The lines are simply guides 
for the eye.
FigUre 5 | Distal and fall-off region of the sOBP shown in Figure 4.
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LET, rather than a single LET value. This issue has been discussed 
for carbon beams by Belli et al. (31), who suggested that these 
differences between SOBP and monoenergetic beams may also 
depend on the specific cell line, in addition to the ion type. More 
specifically, according to these authors, a systematic deviation 
may be related to the averaging procedures in the presence of 
a LET distribution along the SOBP. Moreover, if this distribu-
tion is large enough to include high-LET values falling close to 
or beyond the RBE maximum, the so-called “overkilling effect” 
might result in a further decrease in biological effectiveness (31).
applications for Protontherapy
After reproducing the survival curves reported in Chaudhary 
et al. (17) for the pristine peaks and the various SOBP positions, 
the model was applied to investigate the depth- and dose depend-
ence of the beam effectiveness along the SOBP, in terms of both 
cell death and chromosome aberrations. For different depths in 
water of the SOBP dose profile reported in Chaudhary et al. (17), 
Figures 4 and 5 report the relative fraction of inactivated cells 
and the relative yield of dicentrics, assuming a dose of 2 Gy in 
the plateau region. The term “relative” means that each quantity 
FigUre 9 | ri (ratio between proton-induced and X-ray-induced cell 
inactivation after the same dose, blue symbols), rla (ratio between 
proton-induced and X-ray-induced lethal aberrations after the same 
dose, red symbols), and rDic (ratio between proton-induced and 
X-ray-induced dicentrics after the same dose, green symbols) for the 
(dose-averaged) leT values corresponding to the depth positions 
considered in Figure 8. The lines are simply guides for the eye.
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was normalized with respect to the proximal point. For the 
six depth positions considered in the experimental work (i.e., 
1.52, 19.22, 24.28, 30.14, 30.82, and 31.22 mm), the cell killing 
calculations did not add substantial information with respect to 
the experimental work. However, the model allowed predicting 
the fraction of surviving cells also for other positions, with focus 
on the dose fall-off region that can be critical for normal tissue 
damage (see Figure  5). Moreover, the model provided predic-
tions of chromosome aberrations, which were not investigated 
in Chaudhary et al. (17). This information may be useful in the 
framework of normal tissue damage evaluation, since certain 
types of chromosome aberrations (typically, reciprocal transloca-
tions) are known to be related to cell conversion to malignancy 
(15). For this reason, dicentric yields were shown in Figures 4 
and 5: dicentric yields are thought to be not significantly different 
than the yields of reciprocal translocations, which are the sym-
metrical counterpart of dicentrics among inter-chromosomal 
simple exchanges.
Consistent with the experimental data reported in Chaudhary 
et al. (17) and with other works available in the literature [e.g., 
Ref. (4, 32, 33)], the beam effectiveness – both for cell death and 
for chromosome aberrations – was found to increase with depth 
along the plateau, and high levels of biological damage were 
also found beyond the distal fall-off. For instance at ~31 mm in 
water, where the physical dose was about 40% of the proximal 
dose, the fraction of inactivated cells was almost 80% of the 
fraction of inactivated cell at the proximal position. This can 
be explained taking into account that, as protons slow down, 
their LET increases leading to a higher biological effectiveness. 
Furthermore, the (relative) increase in chromosome aberrations 
with increasing depth along the plateau was more pronounced 
with respect to cell killing: while cell killing increased by a factor 
~1.1, the yield of dicentrics (and, thus, reciprocal translocations) 
in the distal position was more than 1.4 times higher with respect 
to the proximal position. This is an example of dependence of 
biological effectiveness on the considered endpoint.
Predictions of cell death and chromosome aberrations were 
also performed assuming different plateau doses. Figures 6 and 
7 report predictions for the fraction of inactivated cells (Figure 6) 
and the mean number of dicentrics per cell (Figure 7) at different 
depths of the SOBP, assuming a plateau dose of 1 or 4 Gy. For 
comparison, the figure also reports the results for 2 Gy. Again, 
the results were normalized with respect to the proximal position.
Increasing the physical dose (from 2 to 4  Gy) reduced the 
increase in biological effectiveness along the plateau, whereas 
decreasing the dose (from 2 to 1 Gy) led to an even more pro-
nounced increase in effectiveness. This is consistent with the 
well-known dose-dependence of RBE, which tends to be higher 
at lower doses and vice versa. However, while for cell death, the 
highest considered dose (4 Gy) led to an almost flat biological 
effectiveness along the plateau; for chromosome aberrations, 
even that dose implied an increase in effectiveness.
To compare the effectiveness of protons with that of X-rays, 
the ratio between the level of effect (cell death or chromosome 
aberrations) induced by a given dose of protons and the level of 
effect induced by the same dose of X-rays was also investigated 
for different positions along the SOBP dose profile. Although this 
quantity has not the same meaning as the RBE, which is defined 
as the iso-effect ratio between the X-ray dose and the proton 
dose, both these ratios reflect variations in biological effective-
ness. Figure 8 reports, for different depths along the SOBP dose 
profile assuming a plateau dose of 2  Gy, the calculated ratio 
between proton-induced cell death (i.e., fraction of inactivated 
cells) and cell death induced by the same dose of X-rays. This 
ratio will be called RI, where “I” means “inactivation.” The figure 
also reports the ratio between the yield of lethal aberrations (i.e., 
mean number of lethal aberrations per cell) induced by protons 
and the yield of lethal aberrations induced by the same dose of 
X-rays, which will be called RLA, as well as the ratio between the 
yield of dicentrics induced by protons and the yield of dicentrics 
induced by the same dose of X-rays, which will be called RDIC.
As expected, all these ratios increased with depth due to 
the increase in proton LET. However, their depth dependence 
showed different features. In particular, RDIC (ratio between pro-
ton- and X-ray dicentrics) increased up to more than 3.5, whereas 
RLA (ratio between proton- and X-ray lethal aberrations) and RI 
(ratio between proton- and X-ray cell inactivation) increased up 
to about 2. Again, this is an example of different effectiveness 
when different endpoints – even different types of chromosome 
aberrations – are considered. The fact that dicentrics, considered 
as representative of reciprocal translocations, showed a more 
pronounced increase with respect to lethal aberrations and cell 
death may have implications in the evaluation of the risk to 
normal tissues.
In Figure 9, the same quantities reported in Figure 8, that is RI, 
RLA, and RDIC, are plotted as a function of the (dose-averaged) LET, 
rather than as a function of depth. With the exception of the two 
points at the lowest LET, this revealed a basically linear increase 
FigUre 11 | Predicted fraction of inactivated cells (blue symbols) and 
mean number of dicentrics per cell (green symbols) for V79 cells at 
different depths of the sOBP dose profile reported in chaudhary et al. 
(17), which is also shown in the figure (red symbols). Each quantity was 
normalized to the proximal point. The lines are simply guides for the eye.
FigUre 10 | survival curves for V79 cells exposed to four 
monoenergetic proton beams (leT: 7.7, 11.0, 17.8, and 27.6 keV/μm), 
as well as X-rays as a reference. The lines are simulation outcomes, the 
points are experimental data taken from the literature: (32) for X-rays, 
7.7 keV/μm protons and 11.0 keV/μm protons; (34) for X-rays, 17.8 keV/μm 
protons, and 27.6 keV/μm protons.
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of RLA with LET. Therefore, at least for LET values in the range 
~5–25 keV/μm, additional RLA values (where “additional” means 
in correspondence of additional LET values and, thus, additional 
depth positions, with respect to those considered in Figures  8 
and 9) may be derived by linear interpolation. If the yield of lethal 
aberrations induced by the same dose of X-rays is known (for 
instance, from experiments), RLA would then provide the yield 
of lethal aberrations induced by protons (LAp). According to our 
model, LAp would then allow calculating proton cell survival for 
these additional depth positions.
After considering AG human fibroblasts, the model was 
applied to V79 hamster fibroblasts, which are rather radio-
resistant and are widely used in the characterization of hadron 
therapy beams. The final goal consisted of predicting cell death 
and chromosome aberrations for V79 cells along the SOBP dose 
profile used in Chaudhary et al. (17) to irradiate AG01522 cells. 
As a preliminary step, to adjust the model parameters before 
performing such predictions, experimental survival curves taken 
from the literature for V79 cells exposed to different monoen-
ergetic proton beams, as well as X-rays as a reference (32, 34), 
were reproduced. Figure 10 reports calculated survival curves for 
X-rays and four monoenergetic proton beams (with LET values 
in the range 7.7–27.6 keV/μm), together with experimental data 
taken from Ref. (32, 34). All the curves reported in Figure  10 
were obtained with f ≈  0.1. The difference with respect to the 
value used for AG cells, which was ~0.2, may be related to the 
different repair features of these two cell lines. More specifically, 
AG cells are likely to possess a less efficient repair machinery, 
implying higher levels of un-rejoined chromosome fragments 
and, thus, higher f values.
Like for AG01522 cells, also for V79 cells the yield of CLs was 
adjusted separately for each radiation quality, that is for each 
curve. The X-ray curve reported in Figure 10 was obtained using 
a CL yield of 1.5 CL Gy−1⋅cell−1, whereas the four proton curves 
were obtained with CL yields in the range ~2.0–3.2 CL⋅Gy−1⋅cell−1, 
increasing with LET. With these values, the general agreement 
between the simulation outcomes and the experimental data 
reported in Ref. (32, 34) was satisfactory. More specifically, 
for the curve at the lowest LET (7.7 keV/μm), the value of the 
reduced chi-square was 1.8. Higher (reduced) chi-square values 
were found for the other curves, for which the maximum relative 
difference between simulated and measured survival was 47%. 
However, the maximum relative difference with respect to the 
data fits provided in (32, 34) was 35%.
Similarly to AG01522 cells, the CL yields used in the present 
work were lower with respect to previous works in which param-
eter f was not introduced in the model. Furthermore, the CL 
yields for V79 cells were lower than the CL yields for AG01522 
cells exposed to similar radiation qualities, as a consequence of 
the lower radiosensitivity of V79 cells. In fact, as discussed in 
detail in previous works [e.g., Ref. (13)], although the CL yield 
mainly depends on radiation quality, it is also modulated by the 
specific target cell response. This is consistent with the biophysi-
cal meaning of this parameter, which represents a type of DNA 
damage that is severe and difficult to be repaired.
Figures 11 and 12 report predictions of cell death (i.e., frac-
tion of inactivated cells) and chromosome aberrations (i.e., mean 
number of dicentrics per cell) for V79 cells along the proton SOBP 
used in Chaudhary et al. (17), as well as the dose profile reported 
in Chaudhary et al. (17). The results, which were obtained assum-
ing a plateau dose of 2 Gy, were normalized with respect to the 
proximal position. Among the considered LET values and, thus, 
the corresponding depth positions, four are those reported in 
Figure 10, whereas the others [i.e., 3.0, 10.1, and 20.0 keV/μm, 
for which the survival data for comparison were taken from Ref. 
FigUre 12 | Distal and fall-off region of the sOBP shown in Figure 11.
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(4, 32, 34), respectively] were not reported in Figure 10 to avoid 
making the figure too crowded.
Like for AG01522 cells, the beam effectiveness was found to 
increase along the plateau, and high levels of biological dam-
age were also found beyond the distal dose fall-off. Moreover, 
the increase in chromosome aberrations along the plateau was 
more pronounced than the increase in cell killing, reflecting the 
radiation effectiveness dependence on the specific endpoint. 
Interestingly, the increase in biological effectiveness was more 
pronounced for V79 cells than for AG01522 cells: for instance, 
for V79 cells the fraction of inactivated cells increased along the 
plateau by a factor that was more than 1.2, whereas for AG01522 
cells this factor was <1.1. This is consistent with the higher RBE 
generally shown by cells exhibiting smaller α/β ratios (7), as is the 
case of V79 cells.
cOnclUsiOn
A biophysical model of radiation-induced cell death and chro-
mosome aberrations, which assumes a pivotal role of DNA 
cluster damage and lethal aberrations, was further developed 
and applied to therapeutic protons. After testing an improved 
version against experimental data, the model was applied to 
pristine and modulated Bragg peaks of the proton beam used to 
treat eye melanoma at INFN-LNS in Catania, Italy. Experimental 
survival curves for AG01522 cells exposed to the Catania beam 
were reproduced. Cell death and chromosome aberrations were 
then predicted at different depth positions along a SOBP dose 
profile, both for AG01522 cells and for V79 cells. In line with 
other studies, this work indicated that assuming a constant RBE 
along a proton SOBP may be sub-optimal. Furthermore, the 
simulations helped quantifying the dependence of the beam 
effectiveness on the considered endpoint and dose, as well as the 
cell radiosensitivity.
More generally, this work provides an example of therapeutic 
beam characterization that is not based on RBE, which can be a 
source of uncertainties. This approach represents a starting point 
in view of possible future works in which treatment plan optimi-
zation may be directly based on the calculated level of biological 
effect (typically, fraction of inactivated cells and yields of chromo-
some aberrations). Of course, to be of practical use, the model 
should be “coupled” to a TPS and/or a radiation transport code. 
Moreover, the model should be further refined, e.g., by extending 
it to other cell lines and correcting the tendency to overestimate 
the effectiveness at the lower survival levels, if this tendency will 
be confirmed.
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